Chronic myeloid leukemia (CML) is a molecularly defined disease and requires the detection of the t(9;22) translocation, resulting in the Philadelphia (Ph) chromosome and the BCR-ABL1 fusion gene [10,11]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.